AzTrials
AzTrials

Cost-effectiveness of Exercise-based Rehabilitation ProgramEFEX-CARENCT01916525

Effectiveness of Exercise Cardiac Rehabilitation

A study testing Exercise based cardiac rehabilitation in people with Cost-effectiveness of Exercise-based Rehabilitation Program, run by University of Oulu at 1 site in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this multidisciplinary study is to employ health-economic evaluation in determining the health benefits achieved with exercise-based cardiac rehabilitation and the costs derived from it compared with conventional post-acute care of cardiac patients in the Finnish health care system. Read more about this study

Who is it for?
Any age
What is being tested?
Exercise based cardiac rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteFinland
Study dates
Feb 2011to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • The patients undergo coronary angiography and are diagnosed with coronary artery disease.

Who cannot join

  • New York Heart Association (NYHA) class IV
  • heart failure
  • unstable chest pain (angina pectoris) at the time of randomization
  • severe peripheral atherosclerosis (intermittent claudication)
  • severe retinopathy or neuropathy related to diabetes.

Trial locations and contacts

1 site in 1 country.

Timo H Mäkikallio, MD contact

+358400574844

timo.makikallio@ppshp.fi

Finland1 site, 1 recruiting
  • Verve

    Oulu, 90101

    Mikko P Tulppo, PhD, +358405081902, mikko.tulppo@verve.fi

    Arto J Hautala, PhD

    Recruiting

Other trials in Finland

About this study

Official title: Effectiveness of Exercise-based Rehabilitation Program for Patients After Acute Coronary Syndrome

The objective of this multidisciplinary study is to employ health-economic evaluation in determining the health benefits achieved with exercise-based cardiac rehabilitation and the costs derived from it compared with conventional post-acute care of cardiac patients in the Finnish health care system.

Read the detailed description

The cost-effectiveness of exercise-based cardiac rehabilitation has not been systematically studied earlier in Finland, and it is not justifiable to directly apply the results of studies done in other countries to circumstances in Finland due to differences in the health care and social security systems between the countries. The research will utilize top Finnish expertise spanning clinical cardiology, health economics, and physical education. The hypothesis is that a quality-adjusted life year of a cardiac patient (cost/QALY) is 20 % less costly in a rehabilitation group than in a conventional post-acute care group.

The participants in the study will be recruited from Oulu University Hospital patients from the Oulu region (n = 300) who have suffered acute coronary syndrome (angiographically diagnosed coronary artery disease). Of these patients, 130 will be randomized to exercise-based cardiac rehabilitation (Verve) and 170 to a control group. Dropping out of the intervention will be mini-mized by means of careful definition of the inclusion criteria and close follow-up. The rehabilitation will seek to implement the most recent international recommendations for health-enhancing physical activity (% of those who achieved the exercise target). Instructions for a progressive training model will be compiled. The amount of exercise will be monitored objectively with a wrist-worn device based on wellness technology. Subjective loading of both the training and health-enhancing physical activity will be monitored using self-evaluation. The study will last one year for each patient, after which cost-effectiveness will be analyzed (University of Eastern Finland). The results of the research will facilitate decision making and choices in Finnish health care when arranging rehabilitation for cardiac patients and planning the optimal utilization of health care resources.

Being tested
Exercise based cardiac rehabilitation
Keywords
Acute coronary syndrome, Cost-effectiveness, Cardiac rehabilitation, Exercise, Physical activity, Home monitoring
Medical subject headings
Acute Coronary Syndrome, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise based cardiac rehabilitationBehavioural

    The cost-effectiveness between the exercise training vs. control groups

Study groups in NCT01916525
Study groupRoleWhat they receive
Exercise based cardiac rehabilitationExperimentalPatients will receive written instructions and a referral to the exercise-based rehabilitation unit. The patient will be taught to use fitness room. Each session of training will be controlled by heart rate. Instruction will also be given for at-home training and filling in a training diary, and training will be scheduled at Verve once a week. On the first visit the patient will receive a device that measures physical activity during the study. Training will also be monitored from the training diary. Structured questionnaires will be used to check compliance and implementation of care will be determined from medication and other health-related habits once a month (during the first 6 months) and finally after 12 months.
Receives: Behavioral: Exercise based cardiac rehabilitation
ControlNo interventionA conventional post-acute care group treated according to finnish guidelines.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cost / quality-adjusted life year of a cardiac patient (QALY)

    Measured: One year / patient

Secondary outcomes (1)
  1. Major Adverse Cardiac Event (MACE)

    significant clinical adverse events, overall mortality, and acute cardiac arrest or resuscitation from cardiac arrest.

    Measured: One year / patient

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2013 (estimated)
  2. Study startFeb 2011
  3. Primary completionDec 2015 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01916525
Sponsor's protocol ID
Verve-139226
Acronym
EFEX-CARE
Status last verified
Aug 2013
First submitted
30 Jul 2013
Last updated
5 Aug 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise based cardiac rehabilitation in people with Cost-effectiveness of Exercise-based Rehabilitation Program, run by University of Oulu at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Timo H Mäkikallio, MD (+358400574844, timo.makikallio@ppshp.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cost / quality-adjusted life year of a cardiac patient (QALY) (time frame: One year / patient). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in